Categories
Jump to navigation
Jump to search
The following categories exist on the wiki, and may or may not be unused. Also see wanted categories.
(first | last) View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)- Anti-CD3 cellular therapy (4 members)
- Anti-CD47 antibodies (1 member)
- Anti-CD52 antibodies (1 member)
- Anti-CD79B antibodies (1 member)
- Anti-CD79B antibody-drug conjugates (1 member)
- Anti-CD7 CAR T-cells (1 member)
- Anti-CLDN18.2 antibodies (1 member)
- Anti-CTLA-4 antibodies (2 members)
- Anti-DKK1 antibodies (1 member)
- Anti-DLL3-CD3 bispecific antibodies (1 member)
- Anti-EGFR-HGFR bispecific antibodies (1 member)
- Anti-EGFR/HGFR bispecific antibodies (0 members)
- Anti-EGFR antibodies (3 members)
- Anti-EGFRvIII CAR T-cells (2 members)
- Anti-EpCAM-CD3 bispecific antibodies (1 member)
- Anti-EpCAM BiTE antibodies (0 members)
- Anti-EpCAM antibodies (1 member)
- Anti-EpCAM bispecific T-cell engager antibodies (0 members)
- Anti-FOLR1 antibodies (1 member)
- Anti-FOLR1 antibody-drug conjugates (1 member)
- Anti-Factor IXa-Factor Xa bispecific antibodies (1 member)
- Anti-Factor IXa antibodies (0 members)
- Anti-Factor XIa antibodies (1 member)
- Anti-Factor Xa antibodies (0 members)
- Anti-GD2 CAR T-cells (1 member)
- Anti-GD2 antibodies (3 members)
- Anti-GD2 cellular therapy (1 member)
- Anti-GP-3 antibodies (1 member)
- Anti-GPIIb-IIIa antibodies (1 member)
- Anti-GPRC5D-CD3 bispecific antibodies (1 member)
- Anti-GPRC5D/CD3 bispecific antibodies (0 members)
- Anti-GPRC5D CAR T-cells (1 member)
- Anti-GPRC5D antibodies (0 members)
- Anti-GPRC5D bispecific T-cell engager antibodies (0 members)
- Anti-GPRC5D cellular therapy (1 member)
- Anti-HER2 antibodies (13 members)
- Anti-HER2 antibody-drug conjugates (2 members)
- Anti-HGFR antibodies (0 members)
- Anti-HGF antibodies (1 member)
- Anti-IFNg antibodies (1 member)
- Anti-IGF-1R antibodies (3 members)
- Anti-IL-2R immunotoxins (1 member)
- Anti-IL-5 antibodies (2 members)
- Anti-IL-6R antibodies (1 member)
- Anti-IL-6 antibodies (1 member)
- Anti-IL3 immunotoxins (0 members)
- Anti-KIR antibodies (1 member)
- Anti-LAG-3 antibodies (1 member)
- Anti-MAGE-A4 SPEAR T-cells (1 member)
- Anti-NGcGM3 antibodies (1 member)
- Anti-P-selectin antibodies (1 member)
- Anti-PD-1 antibodies (14 members)
- Anti-PD-L1 antibodies (6 members)
- Anti-PDGFR antibodies (1 member)
- Anti-PS antibodies (1 member)
- Anti-RANKL antibodies (1 member)
- Anti-SLAMF7 antibodies (1 member)
- Anti-TACSTD2 antibodies (1 member)
- Anti-TACSTD2 antibody-drug conjugates (1 member)
- Anti-TFPI antibodies (1 member)
- Anti-TF antibodies (1 member)
- Anti-TF antibody-drug conjugates (1 member)
- Anti-TRAIL-R1 antibodies (1 member)
- Anti-TRAIL-R2 antibodies (1 member)
- Anti-VEGFR antibodies (1 member)
- Anti-VEGF antibodies (8 members)
- Anti-amyloid antibodies (1 member)
- Anti-c-Met antibodies (1 member)
- Anti-dabigatran antibody fragments (1 member)
- Anti-diarrheals (1 member)
- Anti-mesothelin antibodies (1 member)
- Anti-nectin-4 antibodies (1 member)
- Anti-nectin-4 antibody-drug conjugates (1 member)
- Anti-vWF medications (1 member)
- Antiandrogens (7 members)
- Antibacterials (10 members)
- Antibiotics (4 members)
- Antibody-drug conjugates (11 members)
- Antibody medications (6 members)
- Anticoagulant reversal agents (2 members)
- Anticoagulants (20 members)
- Anticoagulation factors (1 member)
- Antiestrogens (4 members)
- Antifolates (8 members)
- Antifungals (7 members)
- Antihelminthic (1 member)
- Antihistamines (8 members)
- Antileukotrienes (1 member)
- Antimetabolites (25 members)
- Antineoplastic bispecific antibodies (1 member)
- Antineoplastic monoclonal antibodies (41 members)
- Antineoplastics by class effect (5 members)
- Antiparasitic (1 member)
- Antiphospholipid antibody syndrome medications (2 members)
- Antiphospholipid antibody syndrome regimens (1 member)
- Antiplatelet agents (5 members)
- Antipsychotic (2 members)
- Antipyretics (5 members)
- Antithymocyte globulin (3 members)
- Antitumor antibiotics (7 members)